OMAHA, Neb. (July 24, 2013)—UNeMed’s entrepreneur in residence, Gary Madsen, PhD, was featured on KETV’s July 15, 2013 newscast in a video story about his new startup company, ProTransit Nanotherapy L.L.C. The company licensed a technology developed by former University of Nebraska Medical Center researcher Vinod Labhasetwar, Ph.D. The new company plans to use the novel technology to deliver potent antioxidants to tissue beneath skin, which will make existing sunscreens and cosmetics more effective in protecting the skin from cancer, wrinkles and other skin blemishes.
Other news stories featuring ProTransit Nanotherapy:
Drug Delivery, entrepreneur in residence, Gary Madsen, nanotechnology, News, ProTransit Nanotherapy, Vinod Labhashetwar
News ProTransit Nanotherapy lands in local media
UNeMed Corporation is the technology transfer and commercialization office (TTO) for the University of Nebraska Medical Center and the University of Nebraska at Omaha. UNeMed serves all UNMC & UNO researchers, faculty and staff who develop new biomedical technology and inventions, and strives to help bring those innovations to the marketplace. Contact UNeMed at
unemed@unmc.edu or 402-559-2468.
Related Posts
